Filter By Category
Archives
Share on -
ASUNDEXIAN
Generic Name: ASUNDEXIAN
ABSTRACT -
Asundexian is an oral small-molecule inhibitor of activated factor XI (factor XIa), a coagulation target investigated for prevention of thrombotic events with a potentially different bleeding profile from conventional anticoagulants. It has been studied in secondary stroke prevention and other cardiovascular indications. Regulatory status may change; until approved locally, it remains a specialist/investigational antithrombotic agent.
DOSAGE -
Dosage should be determined only by a qualified healthcare professional. Clinical trials have evaluated once-daily oral dosing, including 50 mg in selected secondary-stroke-prevention studies. Routine dosing must follow a clinical-trial protocol or future product label, with careful review of antiplatelet and anticoagulant co-therapy.
SIDE EFFECTS–
- Possible or reported side effects may include:
- Bleeding or bruising
- Anemia
- Headache
- Dizziness
- Nausea
- Laboratory coagulation changes
- Hypersensitivity
- Potential hepatic or renal laboratory changes
ALLERGIC REACTIONS -
Allergic reactions can include rash, hives, swelling, wheezing, or anaphylaxis.
DRUG INTERACTIONS-
Use caution with:
- Antiplatelet agents such as aspirin or P2Y12 inhibitors
- Other anticoagulants
- NSAIDs
- Thrombolytics
- Strong CYP/transporter modulators if identified by label or protocol
- Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, and supplements they are using.
PREAUTIONS–
- Assess bleeding history, recent stroke type, renal/hepatic function, concomitant antithrombotics, and surgical plans.
- Do not combine with anticoagulants unless specifically directed.
WARNINGS –
- Bleeding can be serious even if the class is designed to reduce bleeding risk.
- Investigational status requires specialist oversight.
- Keep out of reach of children.
- In case of overdose, severe reaction, or clinical deterioration, seek immediate medical attention.
Share on -
. Developed by